PI3K signaling in pancreatic β cells has been shown to be important in modulating β cell mass and function under basal condition. Evidence suggests that a specific group of insulin promoter-expressing neurons also modulates glucose metabolism and energy homeostasis through their PI3K signaling. Thus we hypothesize that PI3K activation via PTEN deletion under the control of rat insulin promoter (RIP) in pancreatic β cells and RIP-expressing neurons will protect against hyperglycemia and diabetes in experimentally induced mouse models of type 2 diabetes. In Chapter IV, we showed that RIP-mediated PTEN deletion in pancreatic β cells led to PI3K activation and subsequent increased β cell mass and function, thus protected the mice from high fat diet (HFD)-induced diabetes. Furthermore in the absence of global leptin signaling, β cell-specific PTEN deletion maintained β cell function in the setting of severe insulin resistance, therefore prevented diabetes development. Interestingly, RIP-mediated PTEN deletion also resulted in increased peripheral insulin sensitivity due to PI3K activation in central nervous system. In Chapter V, we showed this increased insulin sensitivity was maintained after HFD feeding, which also contributed to the protection against diabetes. These mice also showed increased visceral adipogenesis and subcutaneous adiposity on HFD, which were dramatically attenuated in the absence of leptin signaling, indicated the essential role of peripheral leptin action in mediating the insulin sensitive phenotype from neuronal RIP PTEN deletion. Finally, we demonstrated that the insulin sensitizing phenotype in these mice was not mediated through ventromedial hypothalamic nuclei (VMH), such that VMH-specific PTEN deletion did not alter energy homeostasis or glucose metabolism. Together, the data from this thesis points to an inhibitory role of PTEN in both central nervous system and pancreatic β cells in glycemic control. Therefore, PTEN may represent a potential target for diabetes prevention and treatment.

An important mechanism involved in the pathogenesis of type 2 diabetes is elevation of plasma free fatty acids which induce insulin resistance and may impair both β-cell function and mass (β-cell lipotoxicity). The objective of my thesis was to investigate the role of oxidative stress in β-cell lipotoxicity, using in vivo, ex vivo, and in vitro models. I used in vivo models of 48h i.v. oleate or olive oil infusion in Wistar rats followed by hyperglycemic clamps, or islet secretion studies ex vivo, and in vitro models of 48h exposure to oleate in isolated islets. My first study showed that 48h oleate infusion decreased the insulin response to a hyperglycemic clamp, an effect prevented by coinfusion of the antioxidants N-acetylcysteine and taurine. Similar to the findings in vivo, 48h infusion of oleate decreased glucose stimulated insulin secretion (GSIS) ex vivo, and induced oxidative stress in isolated islets, effects prevented by coinfusion of the antioxidants N-acetylcysteine, taurine, or tempol. Islets exposed to oleate or palmitate showed a decreased insulin response to high glucose and increased levels of oxidative stress, effects prevented by taurine. Therefore, my data are the first demonstration that oxidative stress plays a role in the decrease in β-cell secretory function induced by prolonged exposure to FFA, in vitro and in vivo. My second study addressed downstream effects of oxidative stress involving inflammation. A 48h infusion of oleate or olive oil decreased β-cell function during a hyperglycemic clamp, an effect prevented by coinfusion of the IKKβ inhibitor salicylate. GSIS in isolated islets was impaired by olive oil or oleate and restored by salicylate. These results suggest a potential role for both oxidative stress and inflammation in lipid-induced β-cell dysfunction. My third study addressed downstream effects of oxidative stress involving β-cell insulin signalling. A 48h infusion of oleate or olive oil decreased β-cell function during a hyperglycemic clamp, an effect prevented by coinfusion of the tyrosine phosphatase inhibitor bisperoxovanadate. GSIS in isolated islets was impaired by olive oil or oleate and restored by bisperoxovanadate, suggesting a role of FFA in decreasing β-cell function by induction of β-cell insulin resistance.

Chronic hyperglycemia, a hallmark of type 2 diabetes, can decrease β-cell function and mass (β-cell glucotoxicity); however, the mechanisms are incompletely understood. The objective was to examine the mechanisms of β-cell glucotoxicity using in vivo and ex vivo models. The hypothesis is that oxidative stress plays a causal role in high glucose-induced β-cell dysfunction in vivo via pathways that involve endoplasmic reticulum (ER) stress and JNK. The model of β-cell glucotoxicity was achieved by prolonged i.v. glucose infusion (to achieve hyperglycemia). In Study 1, 48h glucose infusion increased total and mitochondrial superoxide levels in islets, and impaired β-cell function in vivo and ex vivo. Co-infusion of the superoxide dismutase mimetic Tempol decreased total and mitochondrial superoxide, and prevented high glucose-induced β-cell dysfunction in vivo and ex vivo. These results suggest that increased superoxide generation plays a role in β-cell glucotoxicity. In Study 2, 48h glucose infusion increased activation of the unfolded protein response (XBP-1 mRNA splicing and phospho-eIF2α levels). This was partially prevented by Tempol. Co-infusion of the chemical chaperone 4-phenylbutyrate with glucose decreased spliced XBP-1 levels, and prevented high glucose-induced β-cell dysfunction in vivo and ex vivo. Co-infusion of 4-phenylbutyrate also decreased total and mitochondrial superoxide induced by high glucose. These results suggest that 1) ER stress plays a causal role in high glucose-induced β-cell dysfunction, and 2) there is a link between oxidative stress and ER stress in high glucose-induced β-cell dysfunction in vivo. In Study 3, JNK inhibition using the inhibitor SP600125 in rats or JNK-1 null mice prevented high glucose-induced β-cell dysfunction ex vivo and in vivo. SP600125 prevented high-glucose-induced β-cell dysfunction without decreasing total and mitochondrial superoxide levels. Both Tempol and 4-phenylbutyrate prevented JNK activation induced by high glucose. These results suggest a role of JNK activation in high glucose-induced β-cell dysfunction downstream of increased superoxide generation and ER stress in vivo. Together, the results suggest that 1) oxidative stress, ER stress and JNK activation are causally involved in β-cell glucotoxicity, and 2) High glucose-induced oxidative stress and ER stress are linked, and both impair β-cell dysfunction via JNK activation in vivo.

Bakgrund: I Sverige har 325 000 människor diagnosen typ 2-diabetes. Sjukdomen ställer stora krav på individen. För att sjuksköterskan ska ge en god omvårdnad behövs kunskaper om patientens individuella behov av stöd. Syfte: Syftet var att beskriva patienters upplevelser av sjuksköterskans stöd vid typ 2-diabetes. Metod: Studien genomfördes som en allmän litteraturstudie där nio vetenskapliga artiklar kvalitetsgranskades och analyserades. Resultat: Patienters upplevelser av sjuksköterskans stöd kategoriserades som emotionellt, informativt och värderande stöd. Viktiga faktorer i sjuksköterskans stöd var gemensamt engagemang, tillit, lindring av bördan, att bli sedd som en individ, kunskap genom information, dialog, kontroll och bekräftelse. Diskussion: Två faktorer diskuterades som påverkade upplevelsen av sjuksköterskans stöd. Hur sjuksköterskan gjorde patienterna delaktiga och tillgodosåg patientens individuella behov ansågs vara väsentligt. Slutsats: Det finns ett behov av att belysa hur patienter upplever sjuksköterskans stöd. Genom att sjuksköterskan har insikt i vad ett gott stöd innebär kan patienten få redskap till sjukdomshantering och ett förbättrat välmående. / Background: In Sweden, 325 000 people have the diagnoses of type 2-diabetes. The disease makes great demands on the individual. The nurse needs knowledge about the patient´s individual needs of support to give good nursing care. Aim: The aim was to describe the patients’ experiences of nurse-support in type 2-diabetes. Method: The study was conducted as a literature review and based upon nine scientific articles that were quality assessed and analyzed. Results: The patients’ experiences of nurse-support were categorized as emotional, informational and evaluative support. Important factors given about the nurse´s support was participation by both nurse and patient, trust, easing the burden, to be seen as an individual, knowledge through information, dialogue, control and acknowledgment. Discussion: Two factors were discussed that affected the patients’ experiences of nurse-support. How the nurse included the patients’ in the recovery and management of their disease and catered to the patient´s individual needs that were considered to be essential. Conclusion: There is a need to highlight how the patients’ experience the nurse's given support. Insight from the nurse into what good support means to the patient can improve disease management and well-being.

Typ-2-diabetes är en kronisk välfärdssjukdom som är associerad med livsstilsförändringar. Omvårdnaden av typ-2-diabetes har traditionellt förknippats med egenvård och patientinformation. Det finns en stor kunskap om typ-2-diabetes och vilka konsekvenser det medför. Det är viktigt att Hälso- och sjukvårdspersonal även har kunskap om människors personliga upplevelser av hälsa och välbefinnande vid typ-2-diabetes. Det finns annars en risk att hälso- och sjukvårdpersonalen fokuserar för mycket på sjukdomen och missar den unika sjukdomsupplevelsen. Syftet med denna studie är att beskriva människors upplevelser av att leva med typ-2 diabetes. Metoden som valdes hade en kvalitativ ansats där data samlades in genom intervjuer. Intervjuerna transkriberades och analyserades utifrån kvalitativ innehållsanalys. Resultatet utmynnande i ett överordnat tema balans mellan Trygghet – Otrygghet och aktiviteter som krav och möjligheter ger hanterbarhet. Temat beskrivs utifrån två huvudkategorier och beskrivande underkategorier. Studien visar att människor med typ-2-diabetes generellt erfar en god hälsa och ett gott välbefinnande utifrån deras egna förutsättningar. De levda erfarenheterna och de olika kraven för hanteringen av typ-2-diabetes varierar utifrån varje människa. Detta indikerar att hälso- och sjukvården bör vara uppmärksam på hur människor betraktar sin subjektiva upplevelse av hälsa och välbefinnande utifrån typ-2-diabetes. / Type-2-diabetes is a chronic welfare disease that is associated with life-style changes. Traditionally, the caring of type-2-diabetes has been associated with self-care and patient information. There is an extensive knowledge on type-2-diabetes and which consequences it results in. It is also important that health care professionals also have knowledge on people’s unique experiences of health and well-being living with type-2-diabetes. Otherwise there is a risk that the health care professionals focus too much on the disease and miss the subjective illness behind the unique person. The aim of this study is to describe people’s experiences of living with type-2-diabetes. A qualitative method was chosen. Data was collected through interviews. The interviews were transcribed and analyzed using qualitative content analysis. The authors found one theme; Balance between security – insecurity and the experience of activities as demands and possibilities give manageability. This study shows that people with type-2-diabetes generally experience good health and well-being in terms of their own resources. However, the lived experiences and the different demands of handling type-2-diabetes vary among people. This indicates that the health care professionals need to pay attention to the experiences of the unique person.

No description available.

Bakgrund: I Sverige är det idag 3-4 procent av befolkningen som har diagnosen diabetes mellitus typ 2 och antalet insjuknade ökar kontinuerligt. Diabetes kan leda till allvarliga komplikationer som kärl- och nervförändringar, ögon och njurpåverkan. Sjuksköterskans roll i omvårdnaden är att ge stöd och utföra kontroller för att förhindra komplikationer. Syfte: Beskriva vilket stöd från sjuksköterskan som vuxna med diabetes typ 2 upplever att de är i behov av. Metod: En allmän litteraturstudie med nio vetenskapliga artiklar sammanställdes. Efter genomläsning lyftes ord och meningar ut ur texten, orden skapade slutligen övergripande teman under vilka resultatet presenterats. Resultat: Litteratursammanställningen visade att patienterna vill ha mer kunskap och information, patienterna ansåg även att det var viktigt att de själva fick bestämma över sin vård. Stödet kan delas in under kategorierna, trygghet, förtroende och bekräftelse. Slutsats: De nationella riktlinjerna för diabetesvård säger att patienten ska få kontinuerlig information angående sitt sjukdomstillstånd, det är även enligt Hälso-och Sjukvårdslagen ett krav att patienten har rätt till självbestämmande under rådande sjukdomsbehandling.För att uppnå dessa krav bör sjusköterskan arbeta för att etablera trygghet och förtroende samt att ge bekräftelse. / Background: In Sweden it is currently 3-4 percent of the population who has a diagnosed type 2 diabetes mellitus and the number of patients is increasing steadily. Diabetes can lead to serious complications such as vascular and nervous changes, eye and kidney problems. The Nurse role in the health care is to support and carry out check up´s to prevent complications. Aim: To describe the support that adult with type 2 diabetes feel that they are in need of and what they actually get from the nurse. Method: A literature review of nine scientific papers were compiled. After reading words were highlighted and sentences taken out of the text, these words finally created the broad themes under which the result is presented. Results: The literature summary showed that patients want more knowledge and information, the patients also felt that it was important that they themselves had to decide about their care. The support can be divided into subcategories, confidence, trust and affirmation. Conclusion: The national guidelines for diabetes care, says that patients should receive continuous information about their illness, it is also under the Health Care Act requires that the patient has the right to self-determination in the current therapies.In order to satisfy these demands nurses need to work for establishing confidence, trust and affirmation in patient suffering from diabetes type 2.

Inledning: Det här är en litteraturstudie om sjuksköterskan bemötande av patienter med diabetes typ 2 genom information och motivering till egenvård och livsstilsförändringar. Bakgrund: Diabetes typ 2 är en sjukdom som ständigt ökar världen över liksom fetma. Genom att göra förändringar i livsstilen kan biverkningar av sjukdomen minskas. Syfte: Syftet med litteraturöversikten är att sammanställa och belysa forskning som beskriver sjuksköterskans olika omvårdnadsstrategier i att bemöta och motivera patienter med diabetes typ 2 till att ändra livsstil. Metod: En litteraturöversikt baserad på tio vetenskapliga artiklar. Resultat: Tre områden identifierades: Att motivera till livsstilsförändring, Vikten av bra bemötande och utbildning i egenvård. Genom att sjuksköterskan använder sig av motiverande samtal och utbildning i egenvård ökar chansen att patienten lyckas med en livsstilsförändring. För detta krävs att en god relation mellan sjuksköterska och patient. Detta kan uppnås genom en patient-centrerad vård där sjuksköterskan ser varje patient som en unik individ. Slutsats: Det fordras ytterligare utbildning för sjuksköterskorna för att de ska kunna tillämpa patientutbildning och egenvård med goda resultat. Sjuksköterskorna måste ha förmåga att stödja patienter till egenvård. / Introduction: This is a literature review of nurses nursing strategies in caring for patient with type 2 diabetes Background: Type 2 diabetes is increasing over the world along with obesity. By making changes in lifestyle secondary effects may be reduced. Aim: The aim of the literature review is to compile and illustrate research that describes different nursing strategies in encountering and motivating patients with type 2 diabetes to lifestyle-changes. Method: A literature review using a qualitative analyses approach based on ten scientific articles. Result: Three areas were identified: To motivate lifestyle changes, The importance of a good treatment. By motivating and educating nurse´ may contribute to supporting the patient in lifestyle changes. To succeed in changes a relation build upon nurse-patient are needed, where every patient is seen as a unique individual. Conclusion: Further nurse-education is necessary to make the patients apply self care with good results. Nurses must have the ability to help the patients to self-care.

Background: Self-care is a multi-dimensional concept and has different definitions. Amongthe definitions, Orem’s definition of self-care is more consistent. Orem (1995) argues that,self-care is a personal activity to take care and maintain of own self health and illness andprevention of disease related complications. Aim: The aim of the paper was to investigate the factors that contribute to self-care behavioramong patients with Type 2 DM as argued in the literature. Method: data was collected from the following electronic databases: CINAHL, PubMed,LibHub, SweMed and Google Scholar-to find full texts. Data was analyzed through CriticalAppraisal Skill Programme. To ensure validity and reliability the author were blinded toreduce study bias and articles were selected according their quality. Result: 31 relevant studies were included in the review, among the major findings of the studywere; Age, Social support/network, high income level, high educational attainment and longType 2 DM diagnosis history had a positive predictor in Type 2 DM patients self-carecontributing factors. Conclusion: To improve a Type 2 DM patients self-care activities the present study concludedthat Demographic, Socio-Economic and Social support factors are among the positivecontributors in patients of Type 2 DM successful Self-Care activities. Key words; Blood glucose self-monitoring, self-administration, Self-care, self-medication,Type 2 Diabetes. / The aim of the paper was to investigate the factors that contribute to self-care behavior among patients with Type 2 DM as argued in the literature.

Cytochrome P450¡]CYP¡^2J2, the single member of human cytochromes P450 II J subfamily, plays an important role in the biosynthesis of biologically active cis-epoxyeicosatrienoic acids. An allelic variant named CYP 2J2*7, a relatively frequent G¡÷T substitution at position-50 relative to the transcription start site, which interrupts a critical Sp1 binding site, results in both decreased promoter activity in vitro and reduced circulating levels of CYP2J2 epoxygenase metabolites. Epoxyeicosatrienoic acid (EETs) are endogenously produced and incorporated into membrane phospholipids in the pancreas. Low concentrations of 5,6-EETs stimulate insulin secretion, whereas 8,9-, 11,12-, and 14,15-EETs stimulate glucagon secretion from the pancreas. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. EETs increased PPAR-£\ and PPAR-£^ transcription activity. PPAR-£\ and PPAR-£^ play a key role in the regulation of adipogenesis, lipid metabolism, insulin sensitivity and inflammation. Thus, genetic abnormalities in the function or expression of CYP2J2, the pathogenetic of enzymes may play a role in diabetes. The present study investigates whether CYP 2J2*7 gene polymorphism can be associated with type 2 diabetes in a Chinese population. We studied 2,073 Chinese type 2 diabetes patients and 704 control subjects without. CYP 2J2*7 gene polymorphism was determined by PCR-RFLP and real-time PCR. In both study groups, the genotype frequency distributions of this polymorphism were in Hardy-Weinberg equilibrium. The CYP2J2*7 genotype distribution or allele frequencies were not different between type 2 diabetes and control subjects. Diabetics with young age of onset¡]¡Ø35 years old¡^ had a higher frequency of T variant than that of the age of onset of greater than 35 years old and controls ( GG / GT + TT = 84.2% / 15.8% vs. 90.3% / 9.7% vs. 91.3% / 8.7%¡Fp = 0.018¡Ap = 0.027 ). CYP2J2*7 genotype had a statistically significant association with age of onset ( p for trend = 0.042 ). The HOMA-IR and HOMA-£] values were significantly higher in diabetic patients with young age of onset compared to those of late onset diabetics and controls. CYP2J2*7 polymorphism was associated with HOMA-IR and HOMA-£] in diabetics with young age of onset and controls, subjects and T variants had significant higher value of HOMA-IR and HOMA-£]¡]early onset diabetics¡GGG / GT + TT = 8.9 ¡Ó 6.1 / 6.4 ¡Ó 3.8, p=0.045¡Fcontrols¡GGG / GT + TT = 2.6 ¡Ó 1.1 / 2.1 ¡Ó 0.8, p = 0.007¡^.These findings suggest that CYP 2J2*7 polymorphism may play a role in the pathogenesis of young onset type 2 diabetes and family diabetic history.